{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-028292","form_type":"8-K","ticker":"SONM","cik":"0001178697","company_name":"DNA X, Inc.","filed_at":"2025-12-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.941060+00:00","generated_at":"2026-05-16T12:42:36.928564+00:00","sec_items":["1.01","2.01","2.03","3.02","3.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sonim issues $1.2M convertible note, acquires DNA X DeFi protocol for 19.99% stock","bullets":["Issued $1.2M convertible promissory note to DNA Holdings, 10% interest, due Dec 2026, convertible at $5.50/share.","Acquired 100% of DNA X LLC for 223,201 shares (19.99% of outstanding) – an on-chain DeFi trading protocol.","DNA Holdings receives board nomination rights (1 officer, 1 director) if it holds ≥5% of common stock.","Put option: if DNA X doesn't hit $600M volume or $1M/day revenue by June 2026, DNA Holdings can swap shares back for DNA X.","Exchanged $629,640 of Streeterville note for 148,500 shares at $4.24; remaining Streeterville note ~$2.3M."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-028292","json":"https://secwatch.observer/filing/0001493152-25-028292.json","markdown":"https://secwatch.observer/filing/0001493152-25-028292.md","text":"https://secwatch.observer/filing/0001493152-25-028292.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/0001493152-25-028292-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:42:36.928564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"58ba76a03e7af73bba7bbe3e72103dd548a72e6f","claim":"DNA X, Inc. incurred convertible notes of $1,200,000 with DNA Holdings Venture, Inc. at 10% per annum maturing December 15, 2026.","evidence_excerpt":"issued a convertible promissory note in the original principal amount of $1,200,000 (the “DNA Note”)","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/0001493152-25-028292-index.htm","confidence":0.9},{"claim_id":"ccf2ddcc39758bc2d19769facd13a3ebe740bff2","claim":"DNA X, Inc. completed an acquisition involving DNA Holdings Venture, Inc. for 223,201 shares of the Company’s common stock, representing 19.99% of the outstanding shares of the Company’s common stock as of the date of issuance (closed 2025-12-15).","evidence_excerpt":"the Company purchased 100% of the membership interests in DNA X LLC, a Delaware limited liability company, (“DNA X”) for an aggregate purchase price of 223,201 shares of the Company’s common stock, representing 19.99% of the outstanding shares of the Company’s common stock as of the date of issuance.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/0001493152-25-028292-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001104659-26-057200","ticker":"CUK","company_name":"CARNIVAL PLC","filed_at":"2026-05-07T23:59:59+00:00","headline":"Carnival completes DLC unification and redomiciliation to Bermuda; Carnival plc now a subsidiary","event_type":"other_material","sec_items":["1.02","2.01","3.01","3.02","3.03","5.01","5.03","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: ma_transaction","same SEC item: 2.01, 3.02, 3.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-057200","json":"https://secwatch.observer/filing/0001104659-26-057200.json","markdown":"https://secwatch.observer/filing/0001104659-26-057200.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1125259/000110465926057200/0001104659-26-057200-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/815097/000110465926057200/tm2613680d1_8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"the Company purchased 100% of the membership interests in DNA X LLC, a Delaware limited liability company, (“DNA X”) for an aggregate purchase price of 223,201 shares of the Company’s common stock, representing 19.99% of the outstanding shares of the Company’s common stock as of the date of issuance.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/0001493152-25-028292-index.htm","comparable_excerpt":"On May 7, 2026, Carnival Corporation and Carnival plc completed the unification of their dual listed company structure under a single company, Carnival Corporation Ltd., with Carnival plc as a UK subsidiary of Carnival Corporation Ltd.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1125259/000110465926057200/0001104659-26-057200-index.htm"}},{"accession":"0001437749-26-014595","ticker":"TRCK","company_name":"Track Group, Inc.","filed_at":"2026-05-04T23:59:59+00:00","headline":"Track Group completes $10.3M PIPE and $21M term loan, reduces net debt 63%","event_type":"other_material","sec_items":["1.01","5.02","2.03","3.02","5.03","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: debt_financing","same SEC item: 1.01, 2.03, 3.02, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-014595","json":"https://secwatch.observer/filing/0001437749-26-014595.json","markdown":"https://secwatch.observer/filing/0001437749-26-014595.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1045942/000143774926014595/0001437749-26-014595-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1045942/000143774926014595/trkg20260430_8k.htm"},"side_by_side_evidence":{"fact_type":"debt_financing","source_excerpt":"issued a convertible promissory note in the original principal amount of $1,200,000 (the “DNA Note”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/0001493152-25-028292-index.htm","comparable_excerpt":"On April 30, 2026, the Company and certain subsidiaries of the Company (together with the Company, collectively, the “ Borrowers ”) entered into a Credit Agreement (the “ Credit Agreement ”) by and among the Borrowers, the lenders from time to time party thereto (the “ Lenders ”), and Chatham Capital Management, LLC, as administrative agent for the Lenders (the “ Administrative Agent ”). Pursuant to the Credit Agreement, the Lenders extended a credit facility in the maximum aggregate principal amount of $24.0 million, consisting of (a) a term loan (the “ Term Loan ”) in the principal amount of $21.0 million, which was funded in full on April 30, 2026, (b) a revolving line of credit in the principal amount of $2.0 million and (c) an interest line loan facility (the “ Interest Line Loan Facility ”) in the principal amount of $1.0 million.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1045942/000143774926014595/0001437749-26-014595-index.htm"}},{"accession":"0001213900-26-052884","ticker":"MSPR","company_name":"MSP Recovery, Inc.","filed_at":"2026-05-06T23:59:59+00:00","headline":"MSP Recovery secures $275K in discretionary advances from Hazel and Virage; appoints CRO amid liquidity strain","event_type":"other_material","sec_items":["1.01","2.03","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: debt_financing","same SEC item: 1.01, 2.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-052884","json":"https://secwatch.observer/filing/0001213900-26-052884.json","markdown":"https://secwatch.observer/filing/0001213900-26-052884.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802450/000121390026052884/0001213900-26-052884-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802450/000121390026052884/ea0289507-8k_msprecovery.htm"},"side_by_side_evidence":{"fact_type":"debt_financing","source_excerpt":"issued a convertible promissory note in the original principal amount of $1,200,000 (the “DNA Note”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/0001493152-25-028292-index.htm","comparable_excerpt":"On May 1, 2026, MSP Recovery, Inc. (the “Company”), through its subsidiaries, entered into a letter agreement with Hazel Partners Holdings LLC (“Hazel”), in its capacity as administrative agent and lender under the Company’s existing working capital credit facility (the “Hazel Letter Agreement”) to provide $0.1 million to be used primarily for operating expenses.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1802450/000121390026052884/0001213900-26-052884-index.htm"}},{"accession":"0001493152-26-021548","ticker":"BNC","company_name":"CEA Industries Inc.","filed_at":"2026-05-06T23:59:59+00:00","headline":"CEA Industries President/Director McDonald resigns; enters $10M loan at 9.5% with BitGo Prime","event_type":"other_material","sec_items":["1.01","2.03","5.02","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: debt_financing","same SEC item: 1.01, 2.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-021548","json":"https://secwatch.observer/filing/0001493152-26-021548.json","markdown":"https://secwatch.observer/filing/0001493152-26-021548.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1482541/000149315226021548/0001493152-26-021548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1482541/000149315226021548/form8-k.htm"},"side_by_side_evidence":{"fact_type":"debt_financing","source_excerpt":"issued a convertible promissory note in the original principal amount of $1,200,000 (the “DNA Note”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/0001493152-25-028292-index.htm","comparable_excerpt":"On April 30, 2026, the parties to the Loan Agreement agreed to a loan request for 10 million USDC at a loan fee amount of 9.5% per annum and an initial maturity date of October 30, 2026, with option to renew for additional 6-month terms on a rolling basis.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1482541/000149315226021548/0001493152-26-021548-index.htm"}},{"accession":"0001628280-26-029840","ticker":null,"company_name":"Ares Core Infrastructure Fund","filed_at":"2026-05-04T23:59:59+00:00","headline":"Ares Core Infrastructure Fund acquires Rover Pipeline subsidiaries, assumes ~$1.09B term loan debt","event_type":"other_material","sec_items":["2.03","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: debt_financing","same SEC item: 2.03, 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-029840","json":"https://secwatch.observer/filing/0001628280-26-029840.json","markdown":"https://secwatch.observer/filing/0001628280-26-029840.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2031750/000162828026029840/0001628280-26-029840-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2031750/000162828026029840/aci-20260428.htm"},"side_by_side_evidence":{"fact_type":"debt_financing","source_excerpt":"issued a convertible promissory note in the original principal amount of $1,200,000 (the “DNA Note”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/0001493152-25-028292-index.htm","comparable_excerpt":"On April 28, 2026, in connection with an investment in a portfolio company, Ares Core Infrastructure Fund (the “Fund”) acquired two wholly owned indirect subsidiaries, BCP Renaissance Parent L.L.C. (the “Rover Borrower”) and BCP Renaissance, L.L.C. (the “ Rover Borrower Subsidiary”), who are parties to a Credit Agreement, dated as of October 31, 2017 (as amended, the “Rover Credit Agreement”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2031750/000162828026029840/0001628280-26-029840-index.htm"}},{"accession":"0001213900-26-051696","ticker":"OLOX","company_name":"OLENOX INDUSTRIES INC.","filed_at":"2026-05-04T23:59:59+00:00","headline":"Subsidiary SG Echo LLC files Chapter 11; Olenox continues normal operations","event_type":"other_material","sec_items":["1.03","2.04","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: debt_financing","same SEC item: 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-051696","json":"https://secwatch.observer/filing/0001213900-26-051696.json","markdown":"https://secwatch.observer/filing/0001213900-26-051696.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1023994/000121390026051696/0001213900-26-051696-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1023994/000121390026051696/ea0289100-8k_olenox.htm"},"side_by_side_evidence":{"fact_type":"debt_financing","source_excerpt":"issued a convertible promissory note in the original principal amount of $1,200,000 (the “DNA Note”)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/0001493152-25-028292-index.htm","comparable_excerpt":"The filing of the Chapter 11 Case constitutes an event of default that accelerated obligations under the following material debt instruments and agreements: (i) approximately $4 million (plus any accrued but unpaid interest in respect thereof) under that certain Loan and Security Agreement between SG Echo, LLC and Enhanced Capital Oklahoma Rural Fund, LLC, dated as of September 20, 2024 (the “Enhanced Loan Agreement”).","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1023994/000121390026051696/0001213900-26-051696-index.htm"}},{"accession":"0001104659-26-054975","ticker":null,"company_name":"Fundrise eREIT, LLC","filed_at":"2026-05-04T23:59:59+00:00","headline":"Fundrise eREIT completes merger of seven affiliated REITs; declares May daily distribution","event_type":"other_material","sec_items":["1.01","2.01","5.03","8.01","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: ma_transaction","same SEC item: 1.01, 2.01, 8.01, 9.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-054975","json":"https://secwatch.observer/filing/0001104659-26-054975.json","markdown":"https://secwatch.observer/filing/0001104659-26-054975.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2093809/000110465926054975/0001104659-26-054975-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2093809/000110465926054975/tm2613192d1_8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"the Company purchased 100% of the membership interests in DNA X LLC, a Delaware limited liability company, (“DNA X”) for an aggregate purchase price of 223,201 shares of the Company’s common stock, representing 19.99% of the outstanding shares of the Company’s common stock as of the date of issuance.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/0001493152-25-028292-index.htm","comparable_excerpt":"At 11:59 p.m. Eastern time on April 29, 2026 (the \"Effective Time\"), which was the same for all of the Mergers, for each respective Fundrise Merger Entity, (1) such Fundrise Merger Entity merged into Fundrise eREIT, with Fundrise eREIT as the surviving entity of the Merger","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2093809/000110465926054975/0001104659-26-054975-index.htm"}},{"accession":"0001140361-26-020027","ticker":null,"company_name":"Cannabist Co Holdings Inc.","filed_at":"2026-05-08T23:59:59+00:00","headline":"Cannabist completes $16.5M Delaware asset sale; enters CCAA, halts SEC reporting","event_type":"other_material","sec_items":["2.01","8.01"],"materiality_score":1.0,"calibrated_materiality_score":1.0,"match_reasons":["same fact type: ma_transaction","same SEC item: 2.01, 8.01","same event type: other_material"],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-020027","json":"https://secwatch.observer/filing/0001140361-26-020027.json","markdown":"https://secwatch.observer/filing/0001140361-26-020027.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1776738/000114036126020027/0001140361-26-020027-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1776738/000114036126020027/ef20072660_8k.htm"},"side_by_side_evidence":{"fact_type":"ma_transaction","source_excerpt":"the Company purchased 100% of the membership interests in DNA X LLC, a Delaware limited liability company, (“DNA X”) for an aggregate purchase price of 223,201 shares of the Company’s common stock, representing 19.99% of the outstanding shares of the Company’s common stock as of the date of issuance.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315225028292/0001493152-25-028292-index.htm","comparable_excerpt":"On May 7, 2026, the Cannabist Company Holdings Inc. (the “Company” or “Cannabist”) and Columbia Care Delaware, LLC, a subsidiary of the Company (“Columbia Care Delaware”), completed the previously announced sale (the “Delaware Asset Purchase Agreement”) of substantially all of its assets related to its business operating in Delaware. At the closing of the transactions contemplated by the Delaware Asset Purchase Agreement (the “Closing”), Arboretum DE PermitCo LLC, a Delaware limited liability company (“Buyer”), as successor by assignment to Parma Holdco LLC, a Nevada limited liability company, purchased such assets for a total consideration of $16.5 million, consisting of $14.025 million (subject to customary working capital adjustments) payable at the Closing and the remaining $2.475 million (the “Offset Escrow Amount”) to be escrowed at Closing and to be released to the Company on the date that is twelve months following Closing;","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1776738/000114036126020027/0001140361-26-020027-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}